FMC shares slipped after Barclays downgraded the pesticide maker to Underweight and cut its price target to $13. The firm warned of a tough outlook as FMC projects weaker 2025 revenue and continues to face generic competition and soft pricing. The stock has already fallen over 73% this year, with management seeing limited growth ahead.